Şeref Kömürcü

1.2k total citations
54 papers, 895 citations indexed

About

Şeref Kömürcü is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Şeref Kömürcü has authored 54 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 11 papers in Public Health, Environmental and Occupational Health and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Şeref Kömürcü's work include Palliative Care and End-of-Life Issues (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Cancer Diagnosis and Treatment (6 papers). Şeref Kömürcü is often cited by papers focused on Palliative Care and End-of-Life Issues (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Cancer Diagnosis and Treatment (6 papers). Şeref Kömürcü collaborates with scholars based in Türkiye, Serbia and United States. Şeref Kömürcü's co-authors include Ahmet Özet, Fikret Arpacı, Declan Walsh, Kristine A. Nelson, Bekir Öztürk, Meral Demiralp, Fahriye Oflaz, Cenǵiz Beyan, Lisa Rybicki and Obai Abdullah and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Şeref Kömürcü

51 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şeref Kömürcü Türkiye 17 282 177 147 138 134 54 895
Christopher J. Womack United States 18 62 0.2× 196 1.1× 74 0.5× 164 1.2× 156 1.2× 47 956
Wenke Cheng China 17 84 0.3× 135 0.8× 42 0.3× 108 0.8× 69 0.5× 45 785
Sussanne Börjeson Sweden 20 337 1.2× 271 1.5× 173 1.2× 140 1.0× 133 1.0× 73 1.4k
Anne K. Swisher United States 14 357 1.3× 240 1.4× 176 1.2× 76 0.6× 351 2.6× 58 950
Ciaran M. Fairman United States 19 352 1.2× 330 1.9× 155 1.1× 64 0.5× 117 0.9× 70 841
Julia E. Inglis United States 13 228 0.8× 626 3.5× 75 0.5× 125 0.9× 97 0.7× 31 1.0k
John A. Linton South Korea 22 61 0.2× 229 1.3× 52 0.4× 237 1.7× 62 0.5× 55 1.2k
Brenda Bongaerts Germany 17 144 0.5× 241 1.4× 46 0.3× 116 0.8× 65 0.5× 44 1.2k
Eunju Sung South Korea 23 61 0.2× 265 1.5× 105 0.7× 221 1.6× 164 1.2× 86 1.9k
Mehmet Yokuşoğlu Türkiye 20 86 0.3× 106 0.6× 23 0.2× 70 0.5× 183 1.4× 77 1.1k

Countries citing papers authored by Şeref Kömürcü

Since Specialization
Citations

This map shows the geographic impact of Şeref Kömürcü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şeref Kömürcü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şeref Kömürcü more than expected).

Fields of papers citing papers by Şeref Kömürcü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şeref Kömürcü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şeref Kömürcü. The network helps show where Şeref Kömürcü may publish in the future.

Co-authorship network of co-authors of Şeref Kömürcü

This figure shows the co-authorship network connecting the top 25 collaborators of Şeref Kömürcü. A scholar is included among the top collaborators of Şeref Kömürcü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şeref Kömürcü. Şeref Kömürcü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Başaran, Gül, Erhan Gökmen, Nil Molinas Mandel, et al.. (2024). Artificial intelligence algorithms for recurrence risk score prediction in early-stage breast cancer: A multicenter study of 437 cases.. Journal of Clinical Oncology. 42(16_suppl). 545–545.
2.
Aydoğan, Ümit, et al.. (2016). Coping attitudes of cancer patients and their caregivers and quality of life of caregivers. Indian Journal of Palliative Care. 22(2). 150–150. 15 indexed citations
3.
Kömürcü, Şeref. (2011). Current Status of Palliative Care in Turkey. Journal of Pediatric Hematology/Oncology. 33(Supplement 1). S78–S80. 19 indexed citations
4.
Kanat, Özkan, Ahmet Özet, Selmin Ataergın, et al.. (2010). Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma. Medical Principles and Practice. 19(5). 344–347. 11 indexed citations
5.
Bağçıvan, Gülcan, et al.. (2009). Analysis of Patient-Related Barriers in Cancer Pain Management in Turkish Patients. Journal of Pain and Symptom Management. 38(5). 727–737. 34 indexed citations
6.
Öztürk, Mustafa, Şeref Kömürcü, Selim Kılıç, et al.. (2009). Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation. Supportive Care in Cancer. 17(10). 1295–1299. 8 indexed citations
7.
Türk, Hacı Mehmet, et al.. (2009). An unusual presentation of extramedullary plasmacytoma in testis and review of the literature. Medical Oncology. 27(4). 1378–1380. 6 indexed citations
8.
Arpacı, Fikret, Mükerrem Safalı, Ahmet Özet, et al.. (2009). The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high‐dose chemotherapy in patients with Stage III breast cancer. Journal of Clinical Apheresis. 24(5). 197–204. 1 indexed citations
9.
Ataergın, Selmin, Ahmet Özet, Luis A. Solchaga, et al.. (2008). Long-lasting multiagent chemotherapy in adult high-risk Ewing’s sarcoma of bone. Medical Oncology. 26(3). 276–286. 6 indexed citations
10.
Özet, Ahmet, Bülent Kurt, Şeref Kömürcü, et al.. (2007). Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients.. PubMed. 28(9). 1374–9. 3 indexed citations
11.
Güner, Perihan, Vedat Işıkhan, Şeref Kömürcü, et al.. (2006). Quality of Life and Sociodemographic Characteristics of Patients With Cancer in Turkey. Oncology nursing forum. 33(6). 1171–1176. 22 indexed citations
12.
13.
Arpacı, Fikret, Türker Çetin, Ahmet Özet, et al.. (2004). The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS. Journal of Clinical Apheresis. 19(4). 197–201. 4 indexed citations
14.
Sarhill, Nabeel, Fade Mahmoud, Declan Walsh, et al.. (2003). Evaluation of nutritional status in advanced metastatic cancer. Supportive Care in Cancer. 11(10). 652–659. 119 indexed citations
15.
Ceylan, Süleyman, Onur Hamzaoğlu, Şeref Kömürcü, Cenǵiz Beyan, & S. Yalçin. (2002). Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complementary Therapies in Medicine. 10(2). 94–99. 86 indexed citations
16.
Çetin, Türker, Fikret Arpacı, Mustafa Turan, et al.. (2002). Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation. Nutrition. 18(7-8). 599–603. 34 indexed citations
17.
Sarhill, Nabeel, Declan Walsh, Karen Nelson, Jade Homsi, & Şeref Kömürcü. (2000). Bioelectrical impedance, cancer nutritional assessment, and ascites. Supportive Care in Cancer. 8(4). 341–343. 11 indexed citations
18.
Öztürk, Bekir, Mehmet Güven, Fikret Arpacı, et al.. (2000). Plasma and Erythrocyte Lipid Peroxidation Levels in Patients with Testis Tumor After Orchiectomy. Biological Trace Element Research. 73(2). 181–188. 1 indexed citations
19.
Yıldıran, Ş. T., et al.. (1998). Fusarium fungaemia in severely neutropenic patients: Fusarium‐Fungämie bei hochgradig neutropenischen Patienten. Mycoses. 41(11-12). 467–469. 10 indexed citations
20.
Duman, Taşkın, et al.. (1994). Mean platelet volume and platelecrit in the acute ischemic stroke. 12(6). 249–252. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Womack Breakdown of academic impact, for papers by Wenke Cheng Breakdown of academic impact, for papers by Sussanne Börjeson Breakdown of academic impact, for papers by Anne K. Swisher Breakdown of academic impact, for papers by Ciaran M. Fairman Breakdown of academic impact, for papers by Julia E. Inglis Breakdown of academic impact, for papers by John A. Linton Breakdown of academic impact, for papers by Brenda Bongaerts Breakdown of academic impact, for papers by Eunju Sung Breakdown of academic impact, for papers by Mehmet Yokuşoğlu
Rankless by CCL
2026